New York, NY, United States of America

Karen Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Imago Pharmaceuticals, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen Chen. Retrieved from https://idiyas.com/inventor/karen-chen-rbelu9lz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Karen Chen

Introduction

Karen Chen is a notable inventor based in New York, NY, who has made significant strides in the field of therapeutic antibodies. With a focus on neurodegeneration, her work aims to address critical health challenges associated with diseases like Parkinson's.

Latest Patents

Karen holds a patent for therapeutic antibodies designed for the treatment of neurodegenerative diseases. This invention provides methods for administering therapeutic antibodies to elicit a beneficial immunogenic response against the aggregation of α-synuclein in the brain. The methods are particularly useful for both prophylactic and therapeutic treatment of diseases associated with the formation of Lewy bodies, such as Parkinson's disease.

Career Highlights

Karen is currently employed at Imago Pharmaceuticals, Inc., where she continues to develop innovative solutions in the realm of therapeutic treatments. Her dedication to research and development has positioned her as a key player in her field.

Collaborations

Karen collaborates with Irene Griswold-Prenner, who is also a prominent figure in the research community. Their partnership exemplifies the importance of teamwork in advancing scientific discoveries.

Conclusion

Karen Chen's contributions to the field of therapeutic antibodies highlight her commitment to improving treatments for neurodegenerative diseases. Her innovative work continues to inspire advancements in medical research and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…